Annals of the Rheumatic Diseases: 83 (3)

Editorial

Polymyalgia rheumatica: crafting the future of a simple (but not easy!) clinical syndrome (8 December, 2023) Free
Milena Bond, Christian Dejaco

Viewpoint

New approach to testing treatments for osteoarthritis: FastOA (11 October, 2023)
David Felson, Martin K Lotz, Yuxuan Jin, Morgan Jones, Jason S Kim, Kurt Spindler

Rheumatoid arthritis

In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation (27 November, 2023)
Eleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, Lars Klareskog, Lars Alfredsson, Linda Mathsson-Alm, Monika Hansson, Martin Cornillet, Guy Serre, Rikard Holmdahl, Karl Skriner, Per-Johan Jakobsson, Helga Westerlind, Johan Askling, Johan Rönnelid
Expression quantitative trait loci analysis in rheumatoid arthritis identifies tissue specific variants associated with severity and outcome (18 November, 2023)
Katriona Goldmann, Athina Spiliopoulou, Andrii Iakovliev, Darren Plant, Nisha Nair, Cankut Cubuk, The MATURA Consortium, Paul McKeigue, Michael R Barnes, Anne Barton, Costantino Pitzalis, Myles J Lewis
Single-cell resolution of longitudinal blood transcriptome profiles in rheumatoid arthritis, systemic lupus erythematosus and healthy control pregnancies (30 November, 2023)
Hilde Julie T Lien, Tina T Pedersen, Bente Jakobsen, Arnar Flatberg, Konika Chawla, Pål Sætrom, Mona H Fenstad
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis (24 November, 2023)
David Moulin, Marie Millard, Mahdia Taïeb, Chloé Michaudel, Anne Aucouturier, Antoine Lefèvre, Luis G Bermúdez-Humarán, Philippe Langella, Youssouf Sereme, Kristell Wanherdrick, Preeti Gautam, Xavier Mariette, Philippe Dieudé, Jacques-Eric Gottenberg, Jean-Yves Jouzeau, David Skurnik, Patrick Emond, Denis Mulleman, Jérémie Sellam, Harry Sokol

Spondyloarthritis

CD_99 G1 neutrophils modulate osteogenic differentiation of mesenchymal stem cells in the pathological process of ankylosing spondylitis (17 November, 2023)
Xinzhe Feng, Chen Wang, Boyao Ji, Junjie Qiao, Yihong Xu, Shanbang Zhu, Zhou Ji, Bole Zhou, Wenwen Tong, Weidong Xu

Vasculitis

Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica (6 November, 2023) Free
Eugenio De Miguel, Rositsa Karalilova, Pierluigi Macchioni, Cristina Ponte, Edoardo Conticini, Sharon Cowley, Alessandro Tomelleri, Sara Monti, Irene Monjo, Zguro Batalov, Giulia Klinowski, Paolo Falsetti, David J Kane, Corrado Campochiaro, Alojzija Hočevar
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways (24 November, 2023)
Dimitris Veroutis, Ourania D Argyropoulou, Andreas V Goules, Konstantinos Kambas, Dimitris Anastasios Palamidas, Konstantinos Evangelou, Sophia Havaki, Aikaterini Polyzou, Dimitrios Valakos, Evangelia Xingi, Elli Karatza, Kyriaki A Boki, Alberto Cavazza, Christos Kittas, Dimitris Thanos, Caterina Ricordi, Chiara Marvisi, Francesco Muratore, Elena Galli, Stefania Croci, Carlo Salvarani, Vassilis G Gorgoulis, Athanasios G Tzioufas
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial (11 December, 2023)
Reza Zonozi, Frank B Cortazar, Anushya Jeyabalan, Gabriel Sauvage, Pravarut Nithagon, Noah R Huizenga, Jillian M Rosenthal, Alexander Sipilief, Katherine Cosgrove, Karen A Laliberte, Eugene P Rhee, William F Pendergraft,, John L Niles

Sjögren’s syndrome

Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren’s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial (6 November, 2023)
Thomas Dörner, Martin Kaul, Antónia Szántó, Jui-Cheng Tseng, Athena S Papas, Ilona Pylvaenaeinen, Malika Hanser, Nasri Abdallah, Andrea Grioni, Aida Santos Da Costa, Enrico Ferrero, Peter Gergely, Rainer Hillenbrand, Alexandre Avrameas, Bruno Cenni, Richard M Siegel

Autoinflammatory disorders

Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry (9 December, 2023)
Benjamin de Valence, Marion Delaune, Yann Nguyen, Vincent Jachiet, Mael Heiblig, Alexis Jean, Stanislas Riescher Tuczkiewicz, Pierrick Henneton, Philippe Guilpain, Nicolas Schleinitz, Guillaume Le Guenno, Hervé Lobbes, Valentin Lacombe, Samuel Ardois, Estibaliz Lazaro, Vincent Langlois, Roderau Outh, Julien Vinit, Jean-Philippe Martellosio, Paul Decker, Thomas Moulinet, Yannick Dieudonné, Adrien Bigot, Louis Terriou, Alexandre Vlakos, Baptiste de Maleprade, Guillaume Denis, Jonathan Broner, Marie Kostine, Sebastien Humbert, Francois Lifermann, Maxime Samson, Susann Pechuzal, Achille Aouba, Olivier Kosmider, Jeremie Dion, Sylvie Grosleron, Rim Bourguiba, Benjamin Terrier, Sophie Georgin-Lavialle, Olivier Fain, Arsène Mekinian, Marjolaine Morgand, Thibault Comont, Jerome Hadjadj

Osteoarthritis

OA susceptibility in mice is partially mediated by the gut microbiome, is transferrable via microbiome transplantation and is associated with immunophenotype changes (18 November, 2023)
Emmaline Prinz, Leoni Schlupp, Gabby Dyson, Montana Barrett, Aleksander Szymczak, Cassandra Velasco, Vladislav Izda, Christopher M Dunn, Matlock A Jeffries

Epidemiology

Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO) (10 November, 2023)
Susan Bridgewater, Mwidimi Ndosi, Jill Dawson, Pamela Richards, Christine Silverthorne, Emma Dures, Susan M. Goodman, Catherine Hill, Sarah L. Mackie, Joanna C. Robson

Images in rheumatology

Elderly woman with polyarthritis, heliotrope-like rash, lymphadenopathy and polyneuropathy (17 August, 2023)
Nobuya Abe, Miyuki Bohgaki, Hideki Kasahara

Letters

Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey (14 November, 2023)
Helena Marzo-Ortega, Stephanie Rose Harrison, György Nagy, Pedro M Machado, Dennis G McGonagle, Sibel Zehra Aydin, Raquel Almodovar-González, Wilson Bautista-Molano, Laure Gossec, Ennio Lubrano, Peter Nash, Fernando Pimentel Santos, Enrique R Soriano, Stefan Siebert
Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicity (24 October, 2023)
Cécile M Yelnik, Xianhong Xie, Marta M Guerra, Nathalie Costedoat-Chalumeau, Arezou Khosroshahi, Diane L Kamen, Noa Schwartz, Patricia Katz, Margaret Minett, R Toby Amoss, April Fu, Gaëlle Guettrot-Imbert, Estibaliz Lazaro, Véronique Le Guern, Jim Oates, Maria Dall'Era, Jinoos Yazdany, Anna Molto, Mimi Y Kim, Jane E Salmon
Obinutuzumab in patients with Sjogren’s disease immunised against rituximab (9 November, 2023)
Mathilde Pezot, Gaétane Nocturne, Rakiba Belkhir, Julien Henry, Stephan Pavy, Raphaèle Seror, Xavier Mariette, Samuel Bitoun

Electronic pages

Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ (21 November, 2023) Free
Francesc A Miro-Mur, Jaume Alijotas-Reig, Ariadna Anunciacion-Llunell, Joana Marques-Soares, Enrique Esteve-Valverde, Jose Pardos-Gea
Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Miro-Mur et al
(21 November, 2023) Free
Doruk Erkan, Medha Barbhaiya, Stephane Zuily, Maria Laura Bertolaccini, Rohan Willis, Katrien Devreese
Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ (21 November, 2023) Free
Zihan Tang, Hui Shi, Hong-Lei Liu, Xiaobing Cheng, Junna Ye, Yutong Su, Qiongyi Hu, Jianfen Meng, Haoyu Pan, Chengde Yang, Jialin Teng, Tingting Liu
Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Tang et al
(21 November, 2023) Free
Medha Barbhaiya, Stephane Zuily, Alison M Hendry, Florian Manneville, Francis Guillemin, Karen H Costenbader, Doruk Erkan
Correspondence on “ACR/EULAR antiphospholipid syndrome classification criteria” (21 November, 2023) Free
Jan Damoiseaux, Joyce van Beers
Response to: Correspondence on ‘ACR/EULAR antiphospholipid syndrome classification criteria’ by Damoiseaux and van Beers (21 November, 2023) Free
Medha Barbhaiya, Stephane Zuily, Maria Laura Bertolaccini, Rohan Willis, Katrien Devreese, Doruk Erkan
Correction: Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study
(15 February, 2024) Free
Correction: A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis
(15 February, 2024) Free
Correction: Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis
(15 February, 2024) Free
Correction: Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance
(15 February, 2024)

Main menu

Table of contents

March 2024 - Volume 83 - 3

Editorial

Viewpoint

Rheumatoid arthritis

Spondyloarthritis

Vasculitis

Sjögren’s syndrome

Autoinflammatory disorders

Osteoarthritis

Epidemiology

Images in rheumatology

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

March 2024 - Volume 83 - 3

Editorial

Viewpoint

Rheumatoid arthritis

Spondyloarthritis

Vasculitis

Sjögren’s syndrome

Autoinflammatory disorders

Osteoarthritis

Epidemiology

Images in rheumatology

Letters

Electronic pages

Issue Information